SEC Form 4 · accession 0001179110-18-013429
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory Gene Freitag
Officer — General Counsel · Director
Period of report
Nov 30, 2018
Accepted (ET)
Dec 4, 2018 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 30, 2018 | S | 45,000 | $33.00 | D | 95,865 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Plan") adopted by the reporting person on September 7, 2018, as amended November 9, 2018. The sales resulted in the completion of the Plan so no more shares will be sold pursuant to the Plan.
- F2The price reported is the actual sale price for all of these shares that were sold in multiple transactions. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the sale of the shares.